During the past decade, Greater Dayton Cancer Center conducted 149 clinical trials. In the 10-year time frame, 149 clinical trials started and 50 clinical trials were completed, i.e. on average, 33.6% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 43 clinical trials were completed. i.e. 67.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greater Dayton Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greater Dayton Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Bayer" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Greater Dayton Cancer Center" are "Breast Cancer" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials) and "Recurrent Squamous Cell Lung Carcinoma" (7 trials). Many other conditions were trialed in "Greater Dayton Cancer Center" in a lesser frequency.

Most popular intervention types in "Greater Dayton Cancer Center" are "Drug" (160 trials), "Other" (91 trials), "Biological" (63 trials), "Procedure" (48 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (42 trials), "Laboratory Biomarker Analysis" (35 trials), "Computed Tomography" (30 trials), "Biospecimen Collection" (27 trials) and "Questionnaire Administration" (27 trials). Other intervention names were less common.

The vast majority of trials in "Greater Dayton Cancer Center" are 155 trials for "All" genders, 20 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Greater Dayton Cancer Center". undefined are not yet recruiting, 64 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Greater Dayton Cancer Center, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Greater Dayton Cancer Center, 7 "Phase 1" clinical trials were conducted, 94 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".